{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0173-0887#drug","name":"Trelegy Ellipta","alternateName":"fluticasone furoate, umeclidinium bromide and vilanterol trifenatate","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0173-0887"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA209482"},{"@type":"PropertyValue","propertyID":"UNII","value":"7AN603V4JV|JS86977WNV|40AHO2C6DG"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"b5a81d5a-4648-4c7a-951d-33c014a63c7e"}],"activeIngredient":"FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE","administrationRoute":["RESPIRATORY (INHALATION)"],"dosageForm":"POWDER","manufacturer":{"@type":"Organization","name":"GlaxoSmithKline LLC"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA209482","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b5a81d5a-4648-4c7a-951d-33c014a63c7e","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0173-0887"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-15T00:23:28.905Z"}}